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Summary
We have found that the small population of cells in human marrow that are characterized by
their expression of CD34 can be readily subdivided into two apparently nonoverlapping
subpopulations ofapproximate equal size, one expressing CD45RO and one CD45R. Functional
studies of these subpopulations revealed that all of the primitive erythroid colony-forming cells
(BFU-E) are CD34+ CD45RO+ . Similarly, more primitive cells that give rise to both erythroid
and granulopoietic colony-forming cells afterbeing maintained for.5 wk on confluent irradiated
long-term marrow culture feeder layers, also show this phenotype. In contrast, most granulopoietic
colony-forming cells are CD34+ CD45RO- cells. The differential expression of CD45 isoforms
on distinct functional subpopulations of hemopoietic cells is consistent with the concept that
these molecules play an important role in the differentiation or activation of primitive, normally
quiescent, hemopoietic cells. The presence of CD45RO and the lack of CD45R on human cells
capable of initiating hemopoiesis in the long-term marrow culture system correspond to the
reported lack of CD45R on transplantable hemopoietic stem cells in rodents and may be a useful
addition to strategies for human stem cell purification, or for purging CD45R+ leukemic cells.
T
he leukocyte common antigen (LCA or CD45) is now
known to identify a family of glycoproteins that are ex-
pressed at different concentrations on the surface of different
types of hemopoietic cells (1). The CD45 complex includes
proteins of molecular mass 180 kD, 190 kD, 205 M and
220 kD. All are encoded by the same gene but are translated
from different mRNAs which result from alternative exon
splicing (2). The biologic functions of CD45 molecules in
hemopoietic cells are not known: however, the demonstra-
tion of a 30-40% amino acid identity of two regions of the
cytoplasmic domain of CD45 with a soluble placental pro-
tein phosphotyrosine phosphatase (3) suggests that these mol-
ecules may be involved in the regulation ofprotein phosphor),
lation and signal transduction. This notion is supported by
the observed increase in phosphorylation of the src-related
leukocyte-specific tyrosine kinase p561ck in T cells that have
lost CD45 (4).
Some mAbs to human CD45 recognize epitopes shared
by all CD45 isoforms (2), whereas others appear to bind selec-
tively either to the 180 kD or to the 220 kD isoform. Altera-
tions in the expression of CD45 molecules are knownto occur
during normal hemopoietic cell development in humans with
low levels being characteristic ofmore primitive cells defined
by their co-expression ofCD34 (5). Less is known about the
expression ofthe various CD45 isoforms on hemopoietic pro-
genitor cells. CD45R has been variously reported to be ex-
pressed on a minority (6) or most (7) granulocyte/monocyte
progenitor cells. In view of these conflicting reports and be-
cause antibodies against murine 220 kD (8) and rat B220 (9)
can be used to obtain enriched populations of pluripotent
hemopoietic stem cells from rodents, we studied CD45 iso-
form expression on human hemopoietic progenitorcells, in-
cluding the most primitive populations currently detectable
in normal marrow (10, 11).
Materials and Methods
mAbs.
￿
UCHIA (12) specific for CD45180 kD (anti-CD45RO)
was a gift from Dr. P.C.L. Beverley (ICRF, London, UK). RFB5,
a mAb against CD45R (220 kD) was obtained from the IV Inter-
national Workshop on Leucocyte DifferentiationAntigens. 8G12,
a mAb specific for CD34, was described previously (13). Purified
8G12 antibody was labeled with FITC using standard procedures.
Cells and Immunofluorescence Staining Procedures.
￿
Normal human
bone marrow obtained from consenting donors was separated using
Ficoll Hypaque. The low density leukocyteswere washed in HBSS
with 2% FCS and 0.1% sodium azide (HFN) and incubated at
10' cells/ml with an equal volume of UCHW (undiluted tissue
culture medium), RFB5 (ascitic fluid diluted 1 in 200 to HFN),
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in HFN the cell pellets were resuspended in biotinylated goat
anti-mouse Ig (Jackson Immunoresearch Laboratories, West Grove,
PA), and incubated for 1 h followedby incubation with streptavidin-
R-PE (Molecular Probes, Eugene, OR) together with 8G12-FITC .
After 30 min the cells were washed and resuspended at a concen-
tration of 2 x 106/ml in HFN for sorting .
Flow Cytometry and Functional Assays.
￿
Flow cytometric anal-
yses and cell sorting were performed with a FACStar Plus (Becton
Dickinson, SanJose, CA) . Agate was set using forward light scatter
and 90° scatter signals that would include all lymphocytes, blast
cells, and all hemopoietic progenitor populations to be assayed but
that would exclude most erythrocytes and granulocytes and other
cells with a high 90° scatter signal as described previously (10) .
Cells in the light scatter window were sorted on the basis of green
and red fluorescence and diluted in tissue culture medium to give
a desired concentration for functional analyses. Primitive erythro-
poietic progenitors (BFU-E), multilineage progenitors (CFU-
GEMM), and all classes of granulopoietic progenitors (CFU-GM)
were assayed in methyloellulose cultures as described previously (10) .
The relative frequency of long-term culture initiating cells (LTC-
IC) was estimated by measuring the total number of clonogeneic
cells (BFU-E, CFU-GM, andCFU-GEMM) present in LTC initi-
ated 5wk after seeding the original cells on feeder layers from pre-
established, irradiated, normal marrow adherent layers (10, 11) .
Results
Low density cells in normal humanmarrow samples were
double stained with antibodies against either CD45R or
CD45RO, and against CD34 . Without exception (more than
10 normal individuals tested), both anti-CD45 isoform anti-
bodies subdivided the CD34' cells into two distinct sub-
populations. These appear to represent mutually exclusive
phenotypes in that the percentage of CD34' CD45R' cells
corresponded roughly to the percentage of cells that were
CD34' CD45RO - , and in that almost all CD34' cells
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were stained ifCD45R and CD45RO antibodies were used
together (data not shown) . An example ofthe staining profiles
obtained is shown in Fig. 1 . Only a few percent of the cells
present in the light scatterwindow are stained by anti-CD34
(Fig . 1 A) . Antibodies against CD45R and CD45RO react
with variable numbers ofCD34- cells (Figure 1, B and C),
but each divides the CD34` cells into two populations of
about equal size (Fig. 1, E and F) . These CD34 ` cells do
not stain with the control antibody (Fig . 1 D) . Note that
the staining intensity ofCD45R and CD45RO on CD34+
cells is significantly less than the staining intensity observed
with subsets of CD34- cells.
The distribution offunctionally distinct hemopoietic cells
was investigated by sorting of CD34+ cells on the basis of
CD45RO fluorescence (as shown in Fig . 1) and assaying for
directly clonogenic cells and their precursors (LTC-ICs) . As
shown in Table 1, BFU-E are found consistently and exclu-
sively in the fraction of CD34' CD45RO' cells, although
a significant number of these cells may be lost during the sort-
ing procedure (recovery values of 15-27%) . CFU-GM are
found in both the CD34' CD45RO- and the CD34'
CD45RO' cell fractions, with the majority being found in
the CD34' CD45RO- cell fraction . LTC-ICs are found
predominantly in the CD34' CD45R0' cell fraction . How-
ever, occasionally (as in Exp . 3), a significant number ofclono-
genic cells can be generated in the LTC system from cells
with a CD34', CD45RO - phenotype. Nevertheless, even
in this particular experiment, the cells in the LTC giving rise
to BFU-E were enriched in the CD34' CD45R0' cell
fraction sixfold more than in the CD34' CD45RO - frac-
tion (data not shown), whereas cells giving rise to onlyCFU-
GM were approximately equally distributed . Because most
CFU-GM are CD34' CD45RO - , it is possible that some
granulopoietic progenitors may persist or generate more ma-
ture forms of CFU-GM even after 5 wk in LTC and thus
Figure 1 .
￿
Expression of CD45 isoforms
on cells that express CD34 . Low density
bone marrow cells were double stained for
CD34 and either a control antibody (A
and D), anti-CD45R (B and E), or anti-
CD45RO (C and F) . To facilitate analysis
of the distribution of CD45 isoforms on
(infrequent) cells that express CD34, an ad-
ditional gate on green (CD34) fluorescence
was set to obtain the contour plots shown
in D-F. Fluorescence is plotted on a log
scale. The lines shown in C and F mark
the sort windows of CD34 * cells used for
functional studies (Table 1, Exp. 3) .Table 1.
￿
Expression of CD45RO on Directly Clonogenic Cells and LTC-IC
Discussion
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operationally overlap with LTC-IC. Additionalexperiments
were undertaken with cells doubly stained with anti-CD34
and anti-CD45R. These confirmed the expression of CD45R
on ti90% of CFU-GM and the lack ofexpression of CD45R
on BFU-E (data not shown).
In this report we show that antibodies against CD45R
and CD45RO can readily separate the small CD34+ cell
population present in normal human marrow into two dis-
tinct subpopulations. These studies were greatly facilitated
by the availability ofa new anti-CD34 mAb that was recently
developed in our laboratory (13) and that, unlike all other
anti-CD34 to date, can be directly labelled with FITC without
loss of binding properties. The two CD34 subpopulations
detected with CD45 isoform antibodies are of about equal
size but appear to contain hemopoietic cells at different stages
of development.
Low expression of CD45 common determinants by normal
human clonogenic cells was first reported by Beverley et al.
(14), who used this finding to isolate a highly enriched pro-
genitor cell population from low density bone marrow cell
suspensions after depletion of CD15+ cells. Subsequently,
Shah et al. (5~demonstrated that CD34+ cells express low
levels ofCD45. Because it hadbeen shown that all cells capable
of forming hemopoietic colonies express CD34 (15), these
findings were not unexpected. Our results confirm these ear-
lier observations and demonstrate, in addition, that most,
if not all CD34+ cells express either CD45R or CD45RO.
The relatively low level of expression of CD45 on all
CD34+ cells could explain the apparent discrepancy between
our findings regarding the expression of CD45 isoforms and
those of Katz et al. (6) . In the latter studyonly 11% ofCFU-
GM were found to express CD45R, but in these experiments
cells with low or intermediate CD45R expression were ex-
cluded from the analysis. Strauss et al. (7) reported reactivity
of mAb My11 with most CFU-GM and lack of My11 reac-
tivity with BFU-E. It now seemslikely that My11 reacts with
Lansdorp et al.
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CD45R. This pattern ofreactivity of anti-CD45R antibodies
with myeloid and erythroid colony-forming cells was con-
firmed here and is exactly complementary to the reactivity
pattern seen with anti-CD45RO. Taken together the data
on the expression ofCD45 common determinants on colony-
forming cells and CD34+ cells (5, 14) and CD45 isoforms
on these cells (6, 7; this paper) strongly suggest that hemo-
poietic cells can be subdivided into mutually exclusive sub-
populations based on their expression ofCD45 isoforms. This
situation is reminiscent of the mutually exclusive expression
of CD45 isoforms on CD4+ CD8 - and CD4 -CD8+ pe-
ripheral T cells (2).
The intracellular domain of CD45 molecules appears to
include a region with phosphatase activity (3), and CD45
has been implicated in signal transduction pathways ofboth
T and B cells (16). The segregation of functionally distinct
hemopoietic subpopulations using antibodies against CD45
isoforms suggests that these molecules may play analogous
roles in developing erythroid and granulopoietic cells. We
have shown that LTC-IC, the most primitive hemopoietic
cells in human marrow currently detectable, express predom-
inantly the CD45RO isoform. It will therefore be of interest
to study in greater detail the regulation of CD45 isoform
expression in thesecells as they begin to proliferate and differen-
tiateinto clonogeniccells. Lymphokines such as Ilrl and 11,6
that have been implicated in the activation and proliferation
of primitive hemopoietic cells (17) have also been reported
to upregulate CD45R expression (18).
The lack ofCD45R expression on the most primitive cells
tested in our study is in agreement with studies on CD45R
expression on transplantable hemopoietic stem cells in mice
(8) and rats (9). Conservation during evolution of develop-
mentally regulated expression of CD45 isoforms on hemo-
poietic cells further suggests that the strict regulation ofCD45
isoforms may be related to their functional significance. The
findings reported here also indicate that antibodies against
CD45R may be useful for the depletion of committed (clono-
genic) hemopoietic cells and thus for the purification ofmore
Exp. Fraction sorted
Percent
sorted
Frequency
(per 105)
BFU-E
Enrich-
ment Recovery
Frequency
(per 105)
CFU-GM
Enrich-
ment Recovery
Frequency
(per 2 x 106)
LTC-IC
Enrich-
ment Recovery
1 Unsorted, stained - 416 1 100 358 1 371 1 100
CD34+ CD45RO- 0.9 0 0 0 12,000 34 30 3,220 9 8
CD34+ CD45RO+ 0.9 11,000 27 24 5,680 16 14 24,100 65 58
2 Unsorted - 93 1 100 86 1 630 1 100
CD34+ CD45RO- 0.7 0 0 0 4,220 49 34 100 <1 <1
CD34+ CD45RO+ 1.0 2,550 27 27 849 10 10 21,300 34 33
3 Unsorted - 132 1 100 140 1 204 1 100
CD34+ CD45RO- 0.5 0 0 0 15,700 112 50 12,705 62 28
CD34+ CD45RO+ 0.4 4,930 37 15 2,670 19 7 19,400 95 37primitive human hemopoietic cell populations. Because a
significant proportion of blast cells from acute myeloid leu-
kemia patients-express CD45R (6, 7), depletionof CD45R+
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cells could also be considered in these cases as a strategy for
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